NECVAX-NEO1 in Addition to Checkpoint Inhibitor in Patients With Solid Tumors
Clinical trial NCT05354323 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05354323
- Sponsor
- NEC OncoImmunity AS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-05
- Primary completion
- 2025-12-31
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.